Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0681 |
| Open | 0.0650 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0411 - 0.0705 |
| 52 Week Range | 0.0200 - 0.1300 |
| Volume | 2,828,636 |
| Avg. Volume | 1,236,665 |
| Market Cap | 16.144M |
| Beta (5Y Monthly) | 0.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0450 |
| Earnings Date | Aug 28, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
GB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
LAS VEGAS, NV / ACCESSWIRE / January 25, 2021 / GB Sciences, Inc. (OTCQB:GBLX), through GBS Global Biopharma, Inc.
- ACCESSWIRE
GB Sciences Receives $4,150,000 and Completes the Sale of Its Louisiana Operations to Wellcana Plus
LAS VEGAS, NV / ACCESSWIRE / January 12, 2021 / GB Sciences, Inc. (OTCQB:GBLX) completed the sale of its remaining interest in GB Sciences Louisiana LLC ("GBSLA") on December 16, 2020.
- ACCESSWIRE
GB Sciences Announces Issuance of US Patent for its Proprietary, Cannabinoid-Based Anti-Inflammatory Formulations
LAS VEGAS / ACCESSWIRE / December 8, 2020 / GB Sciences, Inc.
© 2021 Verizon Media. All rights reserved.
